Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 153


Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials.

Je Y, Schutz FA, Choueiri TK.

Lancet Oncol. 2009 Oct;10(10):967-74. doi: 10.1016/S1470-2045(09)70222-0. Epub 2009 Sep 18. Review.


Molecular imaging using contrast-enhanced ultrasound: evaluation of angiogenesis and cell therapy.

Leong-Poi H.

Cardiovasc Res. 2009 Nov 1;84(2):190-200. doi: 10.1093/cvr/cvp248. Epub 2009 Jul 22. Review.


Molecular imaging of endothelial progenitor cell engraftment using contrast-enhanced ultrasound and targeted microbubbles.

Kuliszewski MA, Fujii H, Liao C, Smith AH, Xie A, Lindner JR, Leong-Poi H.

Cardiovasc Res. 2009 Sep 1;83(4):653-62. doi: 10.1093/cvr/cvp218. Epub 2009 Jun 29.


Antiangiogenesis research is booming, as questions and studies proliferate.

Brower V.

J Natl Cancer Inst. 2009 Jun 3;101(11):780-1. doi: 10.1093/jnci/djp150. Epub 2009 May 26. No abstract available. Erratum in: J Natl Cancer Inst. 2009 Jul 1;101(13):915.


A role for VEGF as a negative regulator of pericyte function and vessel maturation.

Greenberg JI, Shields DJ, Barillas SG, Acevedo LM, Murphy E, Huang J, Scheppke L, Stockmann C, Johnson RS, Angle N, Cheresh DA.

Nature. 2008 Dec 11;456(7223):809-13. doi: 10.1038/nature07424. Epub 2008 Nov 9. Erratum in: Nature. 2009 Feb 26;457(7233):1168.


Tumor-vascular interactions and tumor dormancy.

Naumov GN, Folkman J, Straume O, Akslen LA.

APMIS. 2008 Jul-Aug;116(7-8):569-85. doi: 10.1111/j.1600-0463.2008.01213.x. Review.


Tumor dormancy--from basic mechanisms to clinical practice.

Akslen LA, Naumov GN.

APMIS. 2008 Jul-Aug;116(7-8):545-7. doi: 10.1111/j.1600-0463.2008.01209.x. No abstract available.


Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma.

Hahn OM, Yang C, Medved M, Karczmar G, Kistner E, Karrison T, Manchen E, Mitchell M, Ratain MJ, Stadler WM.

J Clin Oncol. 2008 Oct 1;26(28):4572-8. doi: 10.1200/JCO.2007.15.5655.


Osteonecrosis of the jaw related to bevacizumab.

Estilo CL, Fornier M, Farooki A, Carlson D, Bohle G 3rd, Huryn JM.

J Clin Oncol. 2008 Aug 20;26(24):4037-8. doi: 10.1200/JCO.2007.15.5424. No abstract available.


Dual-targeted contrast agent for US assessment of tumor angiogenesis in vivo.

Willmann JK, Lutz AM, Paulmurugan R, Patel MR, Chu P, Rosenberg J, Gambhir SS.

Radiology. 2008 Sep;248(3):936-44. doi: 10.1148/radiol.2483072231.


Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice.

Willmann JK, Cheng Z, Davis C, Lutz AM, Schipper ML, Nielsen CH, Gambhir SS.

Radiology. 2008 Oct;249(1):212-9. doi: 10.1148/radiol.2491072050. Epub 2008 Aug 11.


The molecular basis of class side effects due to treatment with inhibitors of the VEGF/VEGFR pathway.

Roodhart JM, Langenberg MH, Witteveen E, Voest EE.

Curr Clin Pharmacol. 2008 May;3(2):132-43. Review.


Modes of resistance to anti-angiogenic therapy.

Bergers G, Hanahan D.

Nat Rev Cancer. 2008 Aug;8(8):592-603. doi: 10.1038/nrc2442. Review.


Sorafenib in advanced hepatocellular carcinoma.

Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J; SHARP Investigators Study Group.

N Engl J Med. 2008 Jul 24;359(4):378-90. doi: 10.1056/NEJMoa0708857.


Ultrasound molecular imaging of cardiovascular disease.

Villanueva FS, Wagner WR.

Nat Clin Pract Cardiovasc Med. 2008 Aug;5 Suppl 2:S26-32. doi: 10.1038/ncpcardio1246. Review.


Aflibercept: AVE 0005, AVE 005, AVE0005, VEGF Trap - Regeneron, VEGF Trap (R1R2), VEGF Trap-Eye.

[No authors listed]

Drugs R D. 2008;9(4):261-9. Review. No abstract available.


Use of H2(15)O-PET and DCE-MRI to measure tumor blood flow.

de Langen AJ, van den Boogaart VE, Marcus JT, Lubberink M.

Oncologist. 2008 Jun;13(6):631-44. doi: 10.1634/theoncologist.2007-0235. Review.


Vascular endothelial growth factor receptor 2 mediates macrophage infiltration into orthotopic pancreatic tumors in mice.

Dineen SP, Lynn KD, Holloway SE, Miller AF, Sullivan JP, Shames DS, Beck AW, Barnett CC, Fleming JB, Brekken RA.

Cancer Res. 2008 Jun 1;68(11):4340-6. doi: 10.1158/0008-5472.CAN-07-6705.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk